Aromasin plus Ovarian Suppression Yields Benefit in High-risk Premenopausal Breast Cancer Patients

20:01 EDT 8 Jul 2018 | Cancer Connect

Premenopausal women with hormone receptor-positive, HER2-negative breast cancer and a high risk of recurrence who are treated with an aromatase […]

More From BioPortfolio on "Aromasin plus Ovarian Suppression Yields Benefit in High-risk Premenopausal Breast Cancer Patients"